查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1448643

全球臨床試驗設備和輔助解決方案市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Clinical Trial Equipment & Ancillary Solutions Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

全球臨床試驗設備和輔助解決方案市場需求預計將從 2023 年的 31 億美元達到 2032 年近 70.2 億美元的市場規模，2024-2032 年研究期間CAGR為 9.5%。

臨床試驗設備和輔助解決方案是指醫學研究中用於收集資料和進行實驗的工具、設備和支援服務。這包括從診斷設備到實驗室儀器的各種設備，以及資料管理、物流和法規遵循支援等輔助服務。這些資源對於確保藥物和醫療保健研究中臨床試驗的順利、可靠執行至關重要。

市場動態

臨床試驗設備和輔助解決方案市場受到臨床試驗數量不斷增加、醫學研究進步以及慢性病盛行率上升等因素的推動。臨床試驗日益複雜，需要各種專業設備和輔助服務，包括資料管理工具、物流和實驗室服務。對精準醫療和個人化治療的重視進一步增加了對先進臨床試驗設備的需求。簡化藥物開發流程的監管支持和措施有助於市場成長。此外，合約研究組織（CRO）的擴張和臨床試驗的全球化推動了對綜合設備和輔助解決方案的需求，推動了整體市場的發展。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球臨床試驗設備和輔助解決方案市場的各個細分市場進行了包容性評估。臨床試驗設備和輔助解決方案產業的成長和趨勢為本研究提供了整體方法。

市場區隔

臨床試驗設備和輔助解決方案市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 採購（購買（設備、輔助設備）、租賃（設備、輔助設備））
  • 供應/物流（運輸、包裝、其他）
  • 服務（校準、設備維修、其他）
  • 其他

按階段

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲臨床試驗設備和輔助解決方案市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。臨床試驗設備和輔助解決方案市場的主要參與者包括 Ancillare, LP、Imperial CRS, Inc.、Woodley Equipment Company Ltd.、Thermo Fisher Scientific, Inc.、Parexel International (MA) Corporation、Emsere (MediCapital Rent)、Quipment SAS、IRM、Marken、Myonex、Yourway。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：臨床試驗設備及輔助解決方案 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按階段分析市場吸引力
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球臨床試驗設備和輔助解決方案市場分析：按產品

  • 按產品概述
  • 歷史和預測數據
  • 按產品分析
  • 採購（購買（設備、輔助設備）、租賃（設備、輔助設備））
  • 供應/物流（運輸、包裝、其他）
  • 服務（校準、設備維修、其他）
  • 其他

第 6 章：全球臨床試驗設備和輔助解決方案市場分析：按階段

  • 分階段概覽
  • 歷史和預測數據
  • 按階段分析
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第 7 章：全球臨床試驗設備和輔助解決方案市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章：臨床試驗設備與輔助解決方案公司的競爭格局

  • 臨床試驗設備及輔助解決方案市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Ancillare
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • LP
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Imperial CRS Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Woodley Equipment Company Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Thermo Fisher Scientific Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Parexel International (MA) Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Emsere (MediCapital Rent)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Quipment SAS
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • IRM
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Marken
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Myonex
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Yourway
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112113697

The global demand for Clinical Trial Equipment & Ancillary Solutions Market is presumed to reach the market size of nearly USD 7.02 Billion by 2032 from USD 3.1 Billion in 2023 with a CAGR of 9.5% under the study period 2024 - 2032.

Clinical trial equipment and ancillary solutions refer to the tools, devices, and support services utilized in medical research studies to collect data and conduct experiments. This encompasses a diverse range of equipment, from diagnostic devices to laboratory instruments, along with ancillary services such as data management, logistics, and regulatory compliance support. These resources are vital for ensuring the smooth and reliable execution of clinical trials in pharmaceutical and healthcare research.

MARKET DYNAMICS

The clinical trial equipment and ancillary solutions market is driven by factors such as the increasing number of clinical trials, advancements in medical research, and the rising prevalence of chronic diseases. The growing complexity of clinical trials necessitates a wide range of specialized equipment and ancillary services, including data management tools, logistics, and laboratory services. The emphasis on precision medicine and personalized therapies further boosts the demand for advanced clinical trial equipment. Regulatory support and initiatives to streamline the drug development process contribute to market growth. Additionally, the expansion of contract research organizations (CROs) and the globalization of clinical trials fuel the demand for comprehensive equipment and ancillary solutions, driving the overall market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of clinical trial equipment & ancillary solutions. The growth and trends of clinical trial equipment & ancillary solutions industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the clinical trial equipment & ancillary solutions market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries))
  • Supply/Logistics (Transportation, Packaging, Others)
  • Service (Calibrations, Equipment Servicing, Others)
  • Others

By Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Trial Equipment & Ancillary Solutions market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Trial Equipment & Ancillary Solutions market include Ancillare, LP, Imperial CRS, Inc., Woodley Equipment Company Ltd., Thermo Fisher Scientific, Inc., Parexel International (MA) Corporation, Emsere (MediCapital Rent), Quipment SAS, IRM, Marken, Myonex, Yourway. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Phase
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries)) Historic and Forecast Sales by Regions
  • 5.5 Supply/Logistics (Transportation, Packaging, Others) Historic and Forecast Sales by Regions
  • 5.6 Service (Calibrations, Equipment Servicing, Others) Historic and Forecast Sales by Regions
  • 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET ANALYSIS BY PHASE

  • 6.1 Overview by Phase
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Phase
  • 6.4 Phase I Historic and Forecast Sales by Regions
  • 6.5 Phase II Historic and Forecast Sales by Regions
  • 6.6 Phase III Historic and Forecast Sales by Regions
  • 6.7 Phase IV Historic and Forecast Sales by Regions

7 . GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS COMPANIES

  • 8.1. Clinical Trial Equipment & Ancillary Solutions Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Ancillare
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. LP
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Imperial CRS Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Woodley Equipment Company Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Thermo Fisher Scientific Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Parexel International (MA) Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Emsere (MediCapital Rent)
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Quipment SAS
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. IRM
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Marken
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Myonex
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Yourway
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries)) Market Sales by Geography (USD MN)
  • Supply/Logistics (Transportation, Packaging, Others) Market Sales by Geography (USD MN)
  • Service (Calibrations, Equipment Servicing, Others) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Phase (USD MN)
  • Phase I Market Sales by Geography (USD MN)
  • Phase II Market Sales by Geography (USD MN)
  • Phase III Market Sales by Geography (USD MN)
  • Phase IV Market Sales by Geography (USD MN)
  • Global Clinical Trial Equipment & Ancillary Solutions Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Clinical Trial Equipment & Ancillary Solutions Report
  • Market Research Process
  • Market Research Methodology
  • Global Clinical Trial Equipment & Ancillary Solutions Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Phase
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries)) Market Sales by Geography (USD MN)
  • Supply/Logistics (Transportation, Packaging, Others) Market Sales by Geography (USD MN)
  • Service (Calibrations, Equipment Servicing, Others) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Phase (USD MN)
  • Phase I Market Sales by Geography (USD MN)
  • Phase II Market Sales by Geography (USD MN)
  • Phase III Market Sales by Geography (USD MN)
  • Phase IV Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.